- Home
- ANL vs NKSH Comparison
ANL vs NKSH Comparison
Compare ANL & NKSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ANL | NKSH |
|---|---|---|
| Founded | 2004 | 1891 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Major Banks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.4M | 243.3M |
| IPO Year | 2022 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ANL | NKSH |
|---|---|---|
| Price | $7.10 | $36.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 196.2K | 14.0K |
| Earning Date | 04-20-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 4.14% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.56 |
| Revenue | N/A | ★ $7,474,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $23.46 |
| Revenue Growth | N/A | ★ 5.68 |
| 52 Week Low | $0.88 | $23.75 |
| 52 Week High | $12.09 | $40.00 |
Technical Indicators
Market Signals| Indicator | ANL | NKSH |
|---|---|---|
| Relative Strength Index (RSI) | 39.77 | 37.65 |
| Support Level | $1.36 | $35.42 |
| Resistance Level | $9.98 | $37.65 |
| Average True Range (ATR) | 0.89 | 0.92 |
| MACD | -0.33 | -0.22 |
| Stochastic Oscillator | 13.03 | 18.77 |
Price Performance
Historical ComparisonAbout ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.